Evaluation of a Belatacept-Based Immunosuppression Regimen in Kidney Transplant Recipients

被引：0
|
作者：
Brisku, R. [1 ]
Rudzik, K. [1 ]
Augustine, J. [2 ]
Eckardt, J. [1 ]
机构：
[1] Cleveland Clin, Pharm, Cleveland, OH 44106 USA
[2] Cleveland Clin, Nephrol, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B209
引用
收藏
页码：S848 / S849
页数：2
相关论文
共 50 条
  • [31] Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned
    Moein, Mahmoudreza
    Huang, Nick
    Yang, Christine J.
    Movileanu, Iulia
    Ecal, Kathleen
    Senay, Ayla
    Dvorai, Reut Hod
    Pankewycz, Oleh
    Shahbazov, Rauf
    Laftavi, Mark
    Saidi, Reza
    TRANSPLANTATION, 2022, 106 (09) : S43 - S43
  • [32] Infection in Patients on Belatacept-Based Regimen After Kidney Transplantation
    Moein, M.
    Lui, J.
    Li, B.
    Iskhagi, S.
    Shahbazov, R.
    Hanlon, M.
    Dvorai, R.
    Yang, C.
    Bahraini, A.
    Saidi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S782 - S782
  • [33] IMMUNOSUPPRESSION WITH BELATACEPT-BASED, CNI-FREE, STEROID-AVOIDING REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 6 MONTH, INTERIM RESULTS
    Grinyo, J. M.
    Marks, W.
    Vincenti, F.
    Kaufman, D.
    Marder, B.
    Woodle, S.
    Citterio, F.
    Agarwal, M.
    Garg, P.
    Lin, C. -S.
    Ferguson, R.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 90 - 91
  • [34] Outcomes in Kidney Transplant Recipients after Conversion from Tacrolimus to Belatacept-Based Regimens.
    Underwood, H.
    Lange, N.
    Hedvat, J.
    Brennan, C.
    Tsapepas, D.
    King, K.
    Husain, S.
    Salerno, D.
    Patel, S.
    Mohan, S.
    Crew, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 697 - 697
  • [35] A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
    Vincenti, F.
    Charpentier, B.
    Vanrenterghem, Y.
    Rostaing, L.
    Bresnahan, B.
    Darji, P.
    Massari, P.
    Mondragon-Ramirez, G. A.
    Agarwal, M.
    Di Russo, G.
    Lin, C. -S.
    Garg, P.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) : 535 - 546
  • [36] Immunosuppression with Belatacept-Based, CNI-Free, Steroid-Avoiding Regimens in Kidney Transplant Recipients: 6 Month, Interim Results.
    Grinyo, J. M.
    Marks, W.
    Vincenti, F.
    Kaufman, D. B.
    Marder, B. A.
    Woodle, S.
    Citterio, F.
    Agarwal, M.
    Garg, P.
    Lin, C. -S.
    Ferguson, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 382 - 382
  • [37] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
  • [38] LONG-TERM OUTCOMES AFTER CONVERSION TO A BELATACEPT-BASED IMMUNOSUPPRESSION IN KIDNEY TRANSPLANT: A MATCHED COHORT STUDY
    Divard, Gillian
    Debiais-Deschamps, Charlotte
    Legendre, Christophe
    Lefaucheur, Carmen
    Aubert, Olivier
    Loupy, Alexandre
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I746 - I747
  • [39] Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors
    Iasella, Carlo J.
    Winstead, Ryan J.
    Moore, Cody A.
    Johnson, Bruce A.
    Feinberg, Ayelet T.
    Morrell, Matthew R.
    Hayanga, J. W. Awori
    Lendermon, Elizabeth A.
    Zeevi, Adriana
    McDyer, John F.
    Ensor, Christopher R.
    TRANSPLANTATION, 2018, 102 (01) : 171 - 177
  • [40] Belatacept for kidney transplant recipients
    Masson, Philip
    Henderson, Lorna
    Chapman, Jeremy R.
    Craig, Jonathan C.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
12345